Company Email Format

Mydecine Innovations Group

Biotechnology Denver, Co, United States 3 employees

Employees: 3

mydecine.com LinkedIn Crunchbase

Mydecine Innovations Group Overview

Headquarters: Denver, Co, United States
Website: mydecine.com
Industry: Biotechnology
Employees: 3
Founded: 2020
Funding: 3.8M
Company Email: Available in AeroLeads

Keywords

mycology fungi psychedelics genetics therapy telehealth clinical trials drug development Intelectual property mental health addiction

About Mydecine Innovations Group

Mydecine Innovations Group™ (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) is a biotechnology company developing innovative first- and second-generation novel therapeutics for the treatment of mental health and addiction through world-class technology and drug development infrastructure. The company's world-renowned medical and scientific advisory board is progressing a robust research and development (R&D) pipeline of psychedelic derived therapeutics, novel compounds, therapies, and controlled drug delivery systems.

Mydecine Innovations Group Contact Details

People in AeroLeads: 3

Mydecine Innovations Group Org Chart

Sample employees and titles

Name	Title	Location	Contact
Gary H. Wynn, Md, Dfapa	Consultant Psychiatrist & Professor	Wellington, New Zealand	View
Rakesh Jetly	Consultant Psychiatrist. Trauma	Ottawa, Ontario, Canada	View
Paul Okello			View